Stocks and Investing Stocks and Investing
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021

Steven Seedhouse Maintained (APLS) at Strong Buy with Increased Target to $116 on, Nov 9th, 2021


Published on 2024-10-27 18:34:37 - WOPRAI, Steven Seedhouse
  Print publication without navigation


Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $102 to $116 on, Nov 9th, 2021.

Steven has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 2 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $39 on, Friday, September 10th, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $38 on, Friday, September 10th, 2021


These are the ratings of the 4 analyists that currently disagree with Steven


  • Elemer Piros of "Roth Capital" Maintained at Strong Buy with Decreased Target to $46 on, Friday, September 10th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $70 on, Friday, September 10th, 2021
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Decreased Target to $69 on, Friday, September 10th, 2021
  • Chris Howerton of "Jefferies" Initiated at Strong Buy and Held Target at $74 on, Thursday, August 19th, 2021